New Drug Development & Regulatory News
TippaPatt Shutterstock
Everest Medicines implements NEFECON reimbursement pricing in China
Everest Medicines has announced that with the official implementation of the latest update of the National Reimbursement Drug List on 1st January 2025, NEFECON(R) will apply the NRDL pricing, which will benefit more IgA nephropathy (IgAN) patients. Read more
9 Jan 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Dragon Claws Shutterstock
Sensorion completes enrolment for audiogene Phase 1/2 Trial
Sensorion has announced the completion of enrolment of patients in the first cohort of the Audiogene Phase 1/2 gene therapy clinical trial. Read more
8 Jan 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Tada Images Shutterstock
Sequana Medical announces FDA approval of alfapump
Sequana Medical NV, has announced that it has received Premarket Approval (PMA) from the US Food and Drug Administration (FDA) to market alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis in the United States. Read more
7 Jan 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Panchenko Vladimir Shutterstock
SpliceBio announces FDA IND clearance of SB-007 to commence phase 1/2 clinical study
SpliceBio has announced that the U.S. Food & Drug Administration (FDA) has cleared its investigational new drug (IND) application for lead program SB-007. Read more
3 Jan 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Tada Images Shutterstock
Gerresheimer announces US Food and Drug Administration (FDA) approval
Gerresheimer announces that the US Food and Drug Administration (FDA) granted SQ Innovation Tentative Approval for Lasix ONYU for the home treatment of fluid overload in congestive heart failure. Read more
30 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
PeopleImages.com - Yuri A Shutterstock
NEC announces interim results from Phase 1 clinical trial
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1. Read more
20 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
rblfmr Shutterstock
Registration opens for INTERPHEX 2025
Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place 1-3 April 2025, at the Javits Center in NYC. Read more
16 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sean Pavone Shutterstock
Europe’s top destination to launch a drug device company revealed
New research released ahead of Pharmapack Europe has ranked the Basel region as the most attractive destination in Europe for launching a new drug device company. Read more
15 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies celebrates with ribbon cutting for latest manufacturing expansion
The Danish life science industry is getting another boost as FUJIFILM Diosynth Biotechnologies celebrates its recent production expansion in Denmark. Read more
14 Jan 2025
Aggreko
Clean power ambition in UK relies on supply chain collaboration
The success of the UK’s energy transition will rely on collaboration between businesses to maintain a robust supply chain, a global energy specialist has warned following the launch of its latest research. Read more
17 Jan 2025
Pharma Manufacturing News + Pharmaceutical Logistics & Distribution News
Mytos
Mytos announces collaboration with Aspen Neuroscience
Mytos has entered into a manufacturing collaboration with Aspen Neuroscience to automate the manufacturing of autologous dopaminergic neuronal precursor cells (DANPCs) for ANPD001, Aspen’s investigational cell therapy program for Parkinson’s disease. Read more
17 Jan 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
SuPatMaN Shutterstock
23andMe launches Discover23 to help accelerate genetics research
23andMe Holding has announced the launch of Discover23, a new research offering enabling authorised collaborators to securely access to the power and diversity of the 23andMe research cohort. Read more
17 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Antag
Joerg Moeller appointed as CEO of Antag Therapeutics
Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has announced the appointment of Joerg Moeller, MD, PhD, as chief executive officer, effective immediately. Read more
17 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Bürkert
Surface Acoustic Wave: flow measurement and prevention of biofilm in WFI loops
Flow control specialist Bürkert has developed a flowmeter that uses Surface Acoustic Wave (SAW) technology that also helps to prevent the formation of biofilms in Water for Injection (WFI) loops. Read more
16 Jan 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
GEODIS
GEODIS Management Board appoints executive VP
GEODIS, specialist in transport and logistics, announces the appointment of Marc Vollet as executive vice-president of GEODIS’s European Road Network Line of Business. Read more
15 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
